Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT01612468
Clinical Trials · NCT01612468
Liraglutide in Type 1 Diabetes
Completed
Phase 4
Liraglutide
(Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Steno Diabetes Center Copenhagen
Enrollment
100
Start date
Jun 2012
Locations
1 site, Denmark
Primary endpoint
Change in HbA1c
View Liraglutide compound reference